Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The price of Standard BioTools Inc (NASDAQ: LAB) closed at $1.08 in the last session, down -5.26% from day before closing price of $1.14. In other words, the price has decreased by -$5.26 from its previous closing price. On the day, 1.34 million shares were traded. LAB stock price reached its highest trading level at $1.13 during the session, while it also had its lowest trading level at $1.0501.
Ratios:
We take a closer look at LAB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.09 and its Current Ratio is at 5.70. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On April 16, 2024, TD Cowen started tracking the stock assigning a Buy rating and target price of $3.50.
On April 04, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $3.25.Jefferies initiated its Buy rating on April 04, 2024, with a $3.25 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 28 ’25 when Casdin Partners Master Fund, L bought 4,820,959 shares for $1.06 per share. The transaction valued at 5,134,321 led to the insider holds 58,846,780 shares of the business.
Black Jeffrey G. bought 57,971 shares of LAB for $123,098 on Nov 12 ’24. On Sep 09 ’24, another insider, Taich Adam, who serves as the Former Officer of the company, bought 45,851 shares for $2.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LAB now has a Market Capitalization of 430053888 and an Enterprise Value of 165981152. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.35 while its Price-to-Book (P/B) ratio in mrq is 0.86. Its current Enterprise Value per Revenue stands at 0.952 whereas that against EBITDA is -1.408.
Stock Price History:
The Beta on a monthly basis for LAB is 1.50, which has changed by -0.5909091 over the last 52 weeks, in comparison to a change of 0.077997446 over the same period for the S&P500. Over the past 52 weeks, LAB has reached a high of $3.04, while it has fallen to a 52-week low of $0.99. The 50-Day Moving Average of the stock is -18.08%, while the 200-Day Moving Average is calculated to be -38.67%.
Shares Statistics:
According to the various share statistics, LAB traded on average about 1.92M shares per day over the past 3-months and 1284260 shares per day over the past 10 days. A total of 377.53M shares are outstanding, with a floating share count of 365.09M. Insiders hold about 3.67% of the company’s shares, while institutions hold 73.82% stake in the company. Shares short for LAB as of 1741910400 were 15728051 with a Short Ratio of 8.17, compared to 1739491200 on 13495961. Therefore, it implies a Short% of Shares Outstanding of 15728051 and a Short% of Float of 8.37.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
